Diaceutics (LON:DXRX) Stock Price Down 0.5%

Diaceutics PLC (LON:DXRX) traded down 0.5% during mid-day trading on Tuesday . The company traded as low as GBX 103 ($1.27) and last traded at GBX 103 ($1.27). 66,364 shares changed hands during mid-day trading, an increase of 10% from the average session volume of 60,601 shares. The stock had previously closed at GBX 103.50 ($1.28).

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group reissued a “buy” rating and issued a GBX 150 ($1.85) target price on shares of Diaceutics in a report on Thursday, March 21st.

Diaceutics Stock Down 0.5 %

The company has a debt-to-equity ratio of 3.07, a current ratio of 7.99 and a quick ratio of 9.92. The stock’s fifty day simple moving average is GBX 101.41 and its 200-day simple moving average is GBX 94.53. The stock has a market cap of £87.22 million, a P/E ratio of 10,500.00 and a beta of 0.42.

Insider Buying and Selling at Diaceutics

In other news, insider Graham Paterson purchased 33,564 shares of the company’s stock in a transaction on Wednesday, March 6th. The shares were bought at an average price of GBX 99 ($1.22) per share, for a total transaction of £33,228.36 ($41,042.93). In other Diaceutics news, insider Peter Keeling sold 750,000 shares of the firm’s stock in a transaction that occurred on Thursday, March 28th. The shares were sold at an average price of GBX 102 ($1.26), for a total value of £765,000 ($944,911.07). Also, insider Graham Paterson purchased 33,564 shares of the company’s stock in a transaction on Wednesday, March 6th. The stock was purchased at an average price of GBX 99 ($1.22) per share, for a total transaction of £33,228.36 ($41,042.93). 36.31% of the stock is owned by company insiders.

Diaceutics Company Profile

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide. It operates DXRX platform, which offers DXRX data solutions, including access to various pipelines of diagnostic testing data from a network of laboratories that provides DXRX signal, lab mapping, testing dashboard, and physician mapping services; DXRX marketplace solutions, which enables a marketplace, where labs, pharma, and diagnostic companies come to find partners for collaborations on precision medicine diagnostics.